From the meetings between the Presidents of China and the USA came the slogan, ‘A new model of cooperation’. One item discussed was the proposed $4.6 billion purchase of a US pork producer by a Chinese company, which affirmed: ‘the acquisition won’t affect the quality of the bacon on stateside breakfast tables’.
Increasing demand for Point of Care Testing (POCT) devices leads to an increasing number of nurses and physicians working with unfamiliar equipment. Laboratory-quality test results are available in doctor’s surgeries, out-patient clinics and hospital departments. However, how can a high and comparable quality standard for POCT be guaranteed?
This year’s EuroMedLab and IFCC-EFLM Congress came at a time when all hospitals face ever-increasing healthcare costs, aging populations and patients and GPs demanding more complex and novel diagnostic tests.
Run by Sheffield Teaching Hospitals NHS Trust, the new automated Medical Laboratory at the Northern General Hospital has drawn a previously fragmented service into a purpose-built centre.
If a parameter is determined with different test systems the results must still be comparable. This sounds simple, but is hard to achieve.
The newly relaunched LabsAreVital program will be out in full force at the American Association of Clinical Chemistry (AACC) meeting, from July 28 – August 1 in Houston, Texas.
According to Molly Polen, at the AACC, great opportunities lie ahead for laboratory medicine and, to seize them, ‘meeting with colleagues and learning about new technologies is a critical first step. The 2013 AACC will provide these and other opportunities, such as informative sessions and live demonstrations of new technology.’
EKF Diagnostics has recently marked the production at its manufacturing facility in Barleben, Germany, of the 33,333rd Hemo Control, its globally successful haemoglobin point-of-care analyser, since its launch in 2003.
Evolving technologies and market forces reveal that digital pathology is poised to radically affect the daily workflow and activities of pathologists and diagnostic laboratories
Managing physicians’ test requests is a key ingredient of modern lab management. However, doctors and nurses still do not provide the clinical reasons for orders to all labs.
Demand is increasing for point of care (POC) diagnostic testing, particularly for tests that help foster clinical decision-making within 30 minutes or less.
Snibe, Shenzhen New Industries Biomedical Engineering Co., Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and reagents.
Switzerland treads softly when it comes to governing its 26 independent-minded cantons. Yet, when it comes to electronic medical records, the Ministry of Health holds a particular power, not to dare to direct policy inside any canton, but for the exchange of data between the cantons
Copenhagen’s Hilleroed Hospital now has the world’s most advanced medical laboratory system, providing full automation from the point of drawing a blood sample to results delivery.
Canadian firm Labotix Automation Inc. has been acquired by the Cerner Corporation based in Kansas City, Missouri, USA, amid predictions that the combination of the Labotix’ solution with Cerner Millennium and Cerner Copath will create the most comprehensive set of capabilities on the market to support high volume testing.
Beckman Coulter, Inc. has released a new bench-top haematology analyser for mid- to high-volume laboratories, and upgraded software for HematoFlow.
EKF Diagnostics, worldwide manufacturer of point-of-care diagnostic tools, organ injury biomarkers and assays, has announced the launch of a new division to focus on molecular and companion diagnostics.
Scientists from the German Cancer Research Center (DKFZ) in Heidelberg have been the first to prove that genetic and environmental risk factors for breast cancer do not act independently of each other.
The 2013 turnover expected by German in vitro diagnostics producers are significantly lower compared to last year, according to a survey of members carried out by the German Diagnostics Industry Association (VDGH) presented in January at the Diagnostica Forum in Berlin.
A new test gives reliable results in just 75 minutes, speeding up combat actions. Since Methicillin-resistant staphy lococcus aureus (MRSA) has developed resistance to antibiotic treatments, infections have become a dreaded occurrence in hospitals worldwide.
Aspects of new healthcare legislation are causing concern among medical laboratory experts in the United Kingdom – including the lack of future funding for innovation and development under a new reimbursement model, little appetite to quantify the cost effectiveness of laboratory testing, reduced staffing and a shift in emphasis that will see the need to make profit over-ride initiative and…
Julian Baines, Group CEO of EKF Diagnostics Holdings plc, considers the present role of point of-care tests and their potential value to health services
Over 32% of HIV+ people in Europe remain undiagnosed. This large untapped pool and the development of novel nucleic acid test (NAT) and non-NAT technology based platforms offers growth potential for HIV diagnostics manufacturers.
Founded in 1991 in Shenzhen, China, Mindray is now known internationally for its products that cover patient monitoring and life support, in-vitro diagnostics, medical imaging and veterinary. During Daniela Zimmermann’s interview with David Yin, General Manager of Mindray Europe, he described the firm’s clear strategy for Europe and beyond
In 1963 Greiner Bio-One came into being with the opening of the Greiner Labortechnik production centre for laboratory products in Nürtingen, Germany.